Grantham, Mayo, Van Otterloo & Co (GMO)
MD icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s Pediatrix Medical MD Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$279K Buy
10,995
+1,303
+13% +$29.6K ﹤0.01% 611
2026
Q1 		$207K Buy
+9,692
New +$202K ﹤0.01% 611
2023
Q3 		– Sell
-47,416
Closed -$674K – 642
2023
Q2 		$674K Buy
47,416
+25,716
+119% +$361K ﹤0.01% 532
2023
Q1 		$324K Sell
21,700
-2,200
-9% -$33.3K ﹤0.01% 613
2022
Q4 		$355K Buy
23,900
+1,100
+5% +$17.9K ﹤0.01% 617
2022
Q3 		$376K Buy
+22,800
New +$459K ﹤0.01% 608
2021
Q1 		– Sell
-37,500
Closed -$920K – 902
2020
Q4 		$920K Buy
+37,500
New +$704K 0.01% 577
2016
Q2 		– Sell
-71,400
Closed -$4.61M – 604
2016
Q1 		$4.61M Sell
71,400
-300
-0.4% -$19.9K 0.02% 303
2015
Q4 		$5.14M Buy
71,700
+25,400
+55% +$1.88M 0.02% 251
2015
Q3 		$3.56M Sell
46,300
-700
-1% -$56.5K 0.01% 274
2015
Q2 		$3.48M Sell
47,000
-19,100
-29% -$1.37M 0.01% 287
2015
Q1 		$4.79M Sell
66,100
-21,700
-25% -$1.51M 0.01% 265
2014
Q4 		$5.8M Sell
87,800
-24,401
-22% -$1.49M 0.02% 241
2014
Q3 		$6.15M Sell
112,201
-27,900
-20% -$1.58M 0.02% 249
2014
Q2 		$8.15M Sell
140,101
-16,800
-11% -$989K 0.02% 218
2014
Q1 		$9.72M Buy
156,901
+57,895
+58% +$3.37M 0.03% 209
2013
Q4 		$5.29M Sell
99,006
-7,994
-7% -$429K 0.01% 302
2013
Q3 		$5.37M Sell
107,000
-8,400
-7% -$410K 0.01% 299
2013
Q2 		$5.28M Buy
+115,400
New +$5.17M 0.01% 298

Other funds holding MD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s MD Position: Q2 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) increased its Pediatrix Medical (MD) stake by 13% in Q2 2026, buying an estimated $29.6K and bringing the position to 10,995 shares worth $279K. The position accounts for ﹤0.01% of the portfolio, ranked #611.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in MD in Q2 2013 and has held it in 19 quarters since. The position peaked at $9.72M in Q1 2014. 304 funds tracked by Wall St. Rank hold MD as of Q2 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 10,995 shares of Pediatrix Medical worth $279K as of Q2 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) bought 1,303 Pediatrix Medical shares in Q2 2026, an estimated $29.6K.
  • Pediatrix Medical made up ﹤0.01% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q2 2026, its #611 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Pediatrix Medical in Q2 2013 and has held it in 19 quarters since.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Pediatrix Medical position peaked at $9.72M in Q1 2014.
  • 304 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.